Due to the increase in PTH levels, the occurrence of new subcutaneous, calcific lesions, and the clinical phenotype, pseudohypoparathyroidism, was suspected and the patient was referred for a genetic assessment. The gene discussed is PTH; the disease is pseudohypoparathyroidism type 1A.